In vitro and In vivo Biological Activity of Two Aryloxy-naphthoquinones in Mice Infected with Trypanosoma cruzi Strains.

K Vázquez, A Moreno-Rodríguez… - … (United Arab Emirates …, 2024 - europepmc.org
Background Chagas disease, a condition caused by Trypanosoma cruzi, is an endemic
disease in Latin American countries that affects approximately eight million people …

[HTML][HTML] Biological activities of 1, 4-naphthoquinones derivatives against T. cruzi and L. amazonensis

AO Silva, RS Lopes, AAS Naujorks… - … de Ciencias Químico …, 2022 - scielo.org.co
SUMMARY Introduction: Chagas disease and Leishmaniasis are neglected diseases
caused by the Trypanosoma cruzi and kentoplastid parasites Leishmania spp. Parasitic …

2-Phenylaminonaphthoquinones and related compounds: Synthesis, trypanocidal and cytotoxic activities

I Sieveking, P Thomas, JC Estévez, N Quiñones… - Bioorganic & medicinal …, 2014 - Elsevier
A series of new 2-aminonaphthoquinones and related compounds were synthesized and
evaluated in vitro as trypanocidal and cytotoxic agents. Some tested compounds inhibited …

Expanding the chemical space of aryloxy-naphthoquinones as potential anti-Chagasic agents: Synthesis and trypanosomicidal activity

NA Becerra, C Espinosa-Bustos, K Vázquez… - Medicinal Chemistry …, 2021 - Springer
In continuation our effort to research the chemical space of aryloxy-naphthoquinones as
potential anti-Chagas agents, we synthesized nine derivatives and these compounds were …

2,3-Diphenyl-1,4-Naphthoquinone: A Potential Chemotherapeutic Agent Against Trypanosoma cruzi

EI Ramos, KM Garza, RL Krauth-Siegel… - Journal of …, 2009 - meridian.allenpress.com
Chagas disease, caused by Trypanosoma cruzi, is a widespread infection in Latin America.
Currently, only 2 partially effective and highly toxic drugs, ie, benznidazole and nifurtimox …

Growth inhibitory effect of naphthofuran and naphthofuranquinone derivatives on Trypanosoma cruzi epimastigotes

R Ribeiro-Rodrigues, WG Dos Santos… - Bioorganic & Medicinal …, 1995 - Elsevier
Synthetic and natural naphthofuranquinones were tested in vitro against three Trypanosoma
cruzi strains with different drug susceptibility to nifurtimox and benznidazole in vivo. Four …

Synthesis and biological activity against Trypanosoma cruzi of substituted 1, 4-naphthoquinones

AO da Silva, R da Silva Lopes, RV de Lima… - European Journal of …, 2013 - Elsevier
The discovery and development of essential drugs for Chagas disease is a major concern
worldwide. New substituted 1, 4-naphthoquinones were synthesized and tested against the …

In vitro and in silico evaluations of new aryloxy-1,4-naphthoquinones as anti-Trypanosoma cruzi agents

A González, N Becerra, M Kashif, M González… - Medicinal Chemistry …, 2020 - Springer
In the search for new therapeutic alternatives for Chagas disease, a series of six aryloxy-
naphthoquinone derivatives were synthesized and evaluated in vitro against Trypanosoma …

Naphthoquinones and derivatives for chemotherapy: perspectives and limitations of their anti-trypanosomatids activities

L Dantas-Pereira, EF Cunha-Junior… - Current …, 2021 - ingentaconnect.com
Chagas disease, Sleeping sickness and Leishmaniasis, caused by trypanosomatids
Trypanosoma cruzi, Trypanosoma brucei and Leishmania spp., respectively, are considered …

A Quinoxaline Derivative as a Potent Chemotherapeutic Agent, Alone or in Combination with Benznidazole, against Trypanosoma cruzi

JHS Rodrigues, T Ueda-Nakamura, AG Correa… - PloS one, 2014 - journals.plos.org
Background Chagas' disease is a condition caused by the protozoan Trypanosoma cruzi
that affects millions of people, mainly in Latin America where it is considered endemic. The …